EU Grants €403 Million to Boost Medical Device Innovation in Member States

EU Approves €403 Million to Support Medical Device Companies in its March for the European Health Union

Brussels, 23 July 2025 — In a major step to reinforce Europe’s health technology ecosystem, the European Union has given its green light to a record €403 million in funding for companies that are driving innovation in the medical device sector. The move is widely regarded as a bid to enhance tech sovereignty, strengthen supply chains, and stimulate development of cutting-edge medical technologies across the EU.

The investment, approved under the EU’s Strategic Health Innovation Program (SHIP), will be directed to a consortium comprised of SMEs, research institutes, and “lead users” in medical diagnostics, robotics, wearable health technology, imaging systems, and surgical tools.

Investing in Health Innovation, Urgently

This package is part of a broader push against what many in Europe see as over-reliance on imported medical devices, as they reel from the impact of disrupted supply chains in the pandemic era. The COVID-19 disaster exposed shortcomings in Europe’s capacity to supply and produce essential medical equipment, leading Brussels to place health tech at the core of the wider EU Industrial Strategy.

“We have learned our lessons about preparedness, resilience and the need for strategic autonomy,” said Stella Kyriakides, the EU’s Commissioner for Health and Food Safety.
“This investment represents a real commitment to keeping the EU at the forefront of global medical developments, as well as protecting the health of our citizens.”

Key Focus Areas for the Investment

The €403 million will be distributed via:

• Grants
• Co-investment programmes
• Public-private partnerships

Funds will be co-managed by the European Innovation Council (EIC) and the European Investment Bank (EIB), with a focus on bringing innovations to market quickly and scaling up effectively.

Targeted Sectors for Funding:

• Next-generation diagnostic tools
  AI-augmented imaging, rapid test kits, and biomarker-based disease detection.
• Wearable and remote care devices
  Supporting chronic disease management and preventive care.
• Robotic and surgical automation technologies
  Aiming to improve precision, safety, and save lives.
• Biocompatible materials and implantable devices
  Designed for long-term use, reduced rejection risks, and lower frequency of replacement.
• Digital health solutions and data interoperability
  Supporting precision medicine and improved integration across health systems.

All projects will be evaluated to the highest standards, emphasizing novelty, patient impact, market opportunity, and alignment with EU sustainability and ethical guidelines.

Supporting Europe’s SMEs and Startups

Though large firms like Siemens Healthineers and Philips may participate, the initiative focuses more on Europe’s health tech startup ecosystem. Most invasive medical device companies in the EU are SMEs — many of which are pioneering disruptive innovations.

• €150 million will be directly allocated to early-stage, high-impact startups with limited capital access.

“The European health innovation’s force comes from the diversity and the entrepreneurial spirit of Europe’s start-ups and scale-ups,” said Jean-David Malo, Director of the European Innovation Council.
“This initiative will level the playing field and assist smaller firms in delivering transformational solutions to the market more quickly.”

Addressing Regulatory Hurdles

One of the longstanding challenges for medical device firms in Europe has been navigating the regulatory landscape, which has become more complex following the Medical Device Regulation (MDR) implemented in 2021.

To address this:

• Part of the funding will support technical assistance
• Offer regulatory guidance
• Accelerate access to testing and certification facilities across the EU

The European Medicines Agency (EMA) and national authorities will work with grant recipients to streamline market entry for essential medical devices.

A Boost to Strategic Autonomy

The EU’s focus on medical device innovation is not just economic — it reflects a broader geopolitical transformation.

More than 60% of Europe’s high-value medical devices are imported, primarily from the US and East Asia (source: European Commission).

Reducing this reliance is now seen as essential to:

• Public health security
• Industrial competitiveness

“This initiative is about leadership from Europe and is about lowering risk and lessening dependence,” said Thierry Breton, European Commissioner for the Internal Market.
“Europe should lead on developing the technologies that keep people safe.”

Industry and Research Communities React

The announcement has been welcomed by:

• Industry advocates
• Academic institutions
• Several international stakeholders

The European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR) stated the program is:

“Timely, ambitious, and in line with the critical needs of our sector.”

At the university level, the funding is expected to boost industry-research collaboration.

“Several cross-border consortia have already formed to submit proposals for the program’s initial September deadline.”

Measurable Impact and Future Outlook

The EU Commission aims to:

• Fund 300+ medical innovation projects across more than 20 countries by 2028
• Deliver 100 market-ready devices
• Create up to 10,000 high-tech jobs

Early-Funded Projects Include:

• A Barcelona startup developing real-time telemetric smart cardiac stents
• A Berlin university spinout producing biodegradable surgical implants
• A French-Dutch consortium advancing AI-driven diagnostic imaging for early cancer detection

Annual evaluation reports will be released, with future funding rounds contingent on evolving public health priorities.

Conclusion: A New Era for European Health Tech

With this €403 million investment, the EU is clearly signaling its commitment to a resilient, independent, and innovation-driven health sector.

This funding package:

• Strengthens Europe’s ability to respond to future crises
• Promotes self-reliance
• Prioritizes cutting-edge research and healthcare excellence

By investing today in the tools of tomorrow, the EU is placing health innovation at the heart of its long-term economic and social vision — and setting a powerful example of how science, policy, and enterprise can converge to secure a healthier future for all Europeans.